In this context, GLP-1R agonists show remarkable potential as an emerging therapeutic agent.GLP-1R agonists reduce body weight, lower blood pressure, and improve lipid levels, as well as exerting anti-inflammatory and antioxidant effects by directly acting on GLP-1R in the heart and blood vessels, thereby reducing the risk of atherosclerotic thrombotic events (Solini et al., 2023)
The Asia Pacific Region, including China & India, is growing rapidly because of increasing populations of diabetic patients and those that are obese, better access to healthcare, and the growing awareness of available weight management therapies
Manual entry and barcode are free
Semaglutide offers more safety data and an oral option
right upper quadrant pain, fever or jaundice (possible gallbladder disease)
Nursing implications Fortunately, Ms